<DOC>
	<DOCNO>NCT00455923</DOCNO>
	<brief_summary>An 18 month randomise double-blind study two parallel arm start dose inhaled SERETIDE 50/100mcg BD FLIXOTIDE 100mcg BD , Phase I 6 month patient up-titrated well control achieve , After 6 month treatment continue without change 9 month = PhaseII . The aim investigate evaluate assumption combination therapy SERETIDE control mild persistent asthma well inhaled corticosteroid ( FLIXOTIDE ) alone .</brief_summary>
	<brief_title>SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma ( GINAII )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Willing give inform consent . Males female age 1870 . Able understand complete dairy card . Mild persistent asthma accord GINA . In addition , randomisation subject require : 1 . Day time symptom week every day . 2 . Nighttime symptoms week . 3 . FEV1 &gt; 80 % predict 4 . PC20 &lt; 8mg/mL Change regular asthma medication 4weeks prior visit 1 . Use oral , depot parenteral corticosteroid within 8 week visit 1 . Lower respiratory tract within 4 week Visit 1 Received investigational study drug within 4 week visit Smoking history &gt; 10 pack year . Serious uncontrolled disease . Medical condition medication know affect assessment endpoint . Evidence alcohol drug abuse . Known pregnancy plan pregnancy . Known suspected hypersensitivity inhale corticosteroid , betaagonists lactose . Previous enrollment study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>asthma</keyword>
	<keyword>exacerbation</keyword>
	<keyword>persistent</keyword>
	<keyword>bronchial hyperresponsiveness</keyword>
	<keyword>mild</keyword>
	<keyword>GINAII</keyword>
</DOC>